637 related articles for article (PubMed ID: 23433467)
1. Association of metabolic syndrome traits and severity of kidney stones: results from a nationwide survey on urolithiasis in Japan.
Kohjimoto Y; Sasaki Y; Iguchi M; Matsumura N; Inagaki T; Hara I
Am J Kidney Dis; 2013 Jun; 61(6):923-9. PubMed ID: 23433467
[TBL] [Abstract][Full Text] [Related]
2. Age, Body Mass Index, and Gender Predict 24-Hour Urine Parameters in Recurrent Idiopathic Calcium Oxalate Stone Formers.
Otto BJ; Bozorgmehri S; Kuo J; Canales M; Bird VG; Canales B
J Endourol; 2017 Dec; 31(12):1335-1341. PubMed ID: 29084490
[TBL] [Abstract][Full Text] [Related]
3. Abnormalities of 24-hour urine composition in first-time and recurrent stone-formers.
Eisner BH; Sheth S; Dretler SP; Herrick B; Pais VM
Urology; 2012 Oct; 80(4):776-9. PubMed ID: 22921696
[TBL] [Abstract][Full Text] [Related]
4. Metabolic syndrome and self-reported history of kidney stones: the National Health and Nutrition Examination Survey (NHANES III) 1988-1994.
West B; Luke A; Durazo-Arvizu RA; Cao G; Shoham D; Kramer H
Am J Kidney Dis; 2008 May; 51(5):741-7. PubMed ID: 18436084
[TBL] [Abstract][Full Text] [Related]
5. The characteristics of the stone and urine composition in Chinese stone formers: primary report of a single-center results.
Wu W; Yang D; Tiselius HG; Ou L; Liang Y; Zhu H; Li S; Zeng G
Urology; 2014 Apr; 83(4):732-7. PubMed ID: 24485999
[TBL] [Abstract][Full Text] [Related]
6. Metabolic disorders in Turkish children with urolithiasis.
Celiksoy MH; Yilmaz A; Aydogan G; Kiyak A; Topal E; Sander S
Urology; 2015 Apr; 85(4):909-13. PubMed ID: 25817115
[TBL] [Abstract][Full Text] [Related]
7. Effects of dietary interventions on 24-hour urine parameters in patients with idiopathic recurrent calcium oxalate stones.
Kıraç M; Küpeli B; Irkilata L; Gülbahar O; Aksakal N; Karaoğlan U; Bozkırlı I
Kaohsiung J Med Sci; 2013 Feb; 29(2):88-92. PubMed ID: 23347810
[TBL] [Abstract][Full Text] [Related]
8. Metabolic abnormalities associated with calyceal diverticular stones.
Auge BK; Maloney ME; Mathias BJ; Pietrow PK; Preminger GM
BJU Int; 2006 May; 97(5):1053-6. PubMed ID: 16643491
[TBL] [Abstract][Full Text] [Related]
9. [Metabolic syndrome and nephrolithiasis].
Kohjimoto Y; Iba A; Sasaki Y; Hara I
Hinyokika Kiyo; 2011 Jan; 57(1):43-7. PubMed ID: 21304261
[TBL] [Abstract][Full Text] [Related]
10. Changes in urinary stone risk factors in hypocitraturic calcium oxalate stone formers treated with dietary sodium supplementation.
Stoller ML; Chi T; Eisner BH; Shami G; Gentle DL
J Urol; 2009 Mar; 181(3):1140-4. PubMed ID: 19152919
[TBL] [Abstract][Full Text] [Related]
11. Nephrolithiasis in Cushing's disease: prevalence, etiopathogenesis, and modification after disease cure.
Faggiano A; Pivonello R; Melis D; Filippella M; Di Somma C; Petretta M; Lombardi G; Colao A
J Clin Endocrinol Metab; 2003 May; 88(5):2076-80. PubMed ID: 12727957
[TBL] [Abstract][Full Text] [Related]
12. Correlation of metabolic syndrome with urinary stone composition.
Cho ST; Jung SI; Myung SC; Kim TH
Int J Urol; 2013 Feb; 20(2):208-13. PubMed ID: 23020870
[TBL] [Abstract][Full Text] [Related]
13. Hyperoxaluria, hypocitraturia, hypomagnesiuria, and lack of intestinal colonization by Oxalobacter formigenes in a cervical spinal cord injury patient with suprapubic cystostomy, short bowel, and nephrolithiasis.
Vaidyanathan S; von Unruh GE; Watson ID; Laube N; Willets S; Soni BL
ScientificWorldJournal; 2006 Apr; 6():2403-10. PubMed ID: 17619709
[TBL] [Abstract][Full Text] [Related]
14. Metabolic diagnoses of recurrent stone formers: temporal, geographic and gender differences.
Huynh LM; Dianatnejad S; Tofani S; Carrillo Ceja R; Liang K; Tapiero S; Jiang P; Youssef RF
Scand J Urol; 2020 Dec; 54(6):456-462. PubMed ID: 33185135
[TBL] [Abstract][Full Text] [Related]
15. Nephrolithiasis in medullary sponge kidney: evaluation of clinical and metabolic features.
McPhail EF; Gettman MT; Patterson DE; Rangel LJ; Krambeck AE
Urology; 2012 Feb; 79(2):277-81. PubMed ID: 22014971
[TBL] [Abstract][Full Text] [Related]
16. Physiological and physiochemical correction and prevention of calcium stone formation by potassium citrate therapy.
Pak CY; Sakhaee K; Fuller CJ
Trans Assoc Am Physicians; 1983; 96():294-305. PubMed ID: 6679957
[TBL] [Abstract][Full Text] [Related]
17. A London experience 1995-2012: demographic, dietary and biochemical characteristics of a large adult cohort of patients with renal stone disease.
Ferraro PM; Robertson WG; Johri N; Nair A; Gambaro G; Shavit L; Moochhala SH; Unwin RJ
QJM; 2015 Jul; 108(7):561-8. PubMed ID: 25524906
[TBL] [Abstract][Full Text] [Related]
18. Pediatric urolithiasis--evaluation of risk factors in 95 children.
Erbagci A; Erbagci AB; Yilmaz M; Yagci F; Tarakcioglu M; Yurtseven C; Koyluoglu O; Sarica K
Scand J Urol Nephrol; 2003; 37(2):129-33. PubMed ID: 12745721
[TBL] [Abstract][Full Text] [Related]
19. Association between metabolic syndrome and the presence of kidney stones in a screened population.
Jeong IG; Kang T; Bang JK; Park J; Kim W; Hwang SS; Kim HK; Park HK
Am J Kidney Dis; 2011 Sep; 58(3):383-8. PubMed ID: 21620546
[TBL] [Abstract][Full Text] [Related]
20. Metabolic syndrome and uric acid nephrolithiasis.
Sakhaee K; Maalouf NM
Semin Nephrol; 2008 Mar; 28(2):174-80. PubMed ID: 18359398
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
